1. Dan Hu, Qiong-, Wang, Hong-Lian, Liu, Jian, Lan, Hui-Yao, Wang, Li. 2023. Btg2 Promotes Focal Segmental Glomerulosclerosis via Smad3-Dependent Podocyte-Mesenchymal Transition. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 10, e2304360. doi:10.1002/advs.202304360. https://pubmed.ncbi.nlm.nih.gov/37749872/
2. Yang, Wanting, Wei, Chunli, Cheng, Jingliang, Yang, Yinfeng, Wang, Jinghui. 2023. BTG2 and SerpinB5, a novel gene pair to evaluate the prognosis of lung adenocarcinoma. In Frontiers in immunology, 14, 1098700. doi:10.3389/fimmu.2023.1098700. https://pubmed.ncbi.nlm.nih.gov/37006240/
3. Tirone, F. . The gene PC3(TIS21/BTG2), prototype member of the PC3/BTG/TOB family: regulator in control of cell growth, differentiation, and DNA repair? In Journal of cellular physiology, 187, 155-65. doi:. https://pubmed.ncbi.nlm.nih.gov/11267995/
4. Tsui, Ke-Hung, Chiang, Kun-Chun, Lin, Yu-Hsiang, Feng, Tsui-Hsia, Juang, Horng-Heng. 2017. BTG2 is a tumor suppressor gene upregulated by p53 and PTEN in human bladder carcinoma cells. In Cancer medicine, 7, 184-195. doi:10.1002/cam4.1263. https://pubmed.ncbi.nlm.nih.gov/29239139/
5. Mao, Bijing, Zhang, Zhimin, Wang, Ge. 2014. BTG2: a rising star of tumor suppressors (review). In International journal of oncology, 46, 459-64. doi:10.3892/ijo.2014.2765. https://pubmed.ncbi.nlm.nih.gov/25405282/